Company ProfilePremiumNov 11, 2026

Boehringer Ingelheim International

Company Profile Analysis

Book Demo Register Your Interest

Boehringer Ingelheim International - Healthcare showcase

Year Founded & Workforce

1885

50,370 Employees

Industry

Healthcare

Services

Human Pharma

Boehringer Ingelheim International Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Boehringer Ingelheim International Overview

Company Headquarters: Ingelheim am Rhein, Germany

Founded: 1885

Workforce: ~50,370

Company Working: Boehringer Ingelheim International GmbH (Boehringer Ingelheim) has more than 100 years of legacy. Boehringer Ingelheim GmbH is a highly focused research-driven pharmaceutical company. The main focus of the company is to cure diseases with the help of its core R&D expertise. It constantly works to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies, and on science itself.

Strategy

Boehringer Ingelheim has increased its focus on Asia-Pacific markets to propel its revenue generation. The company also focuses on increasing its production capabilities through strategic partnerships with contract manufacturers.

Company Snapshot

$16,861.7M

Revenue

50,370

Employees

1885

Founded

Ingelheim am Rhein, Germany

Headquarters

SWOT Analysis

Strengths

Strong R&D

Weaknesses

Less revenue generation from few business segments

Opportunities

Collaborations may enhance company's innovative drug pipeline

Threats

Pricing pressures from the government

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

Date	Approach	Development
April 2019	Expansion	Boehringer Ingelheim invested EUR 105 million for expanding its production sites in Dortmund and Ingelheim for the manufacturing of its respiratory products.

Product Offering

Boehringer Ingelheim International
- Human Pharma

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 16,861.7 Mn in 2016 to USD 20,634.4 Mn in 2018.

Boehringer Ingelheim International — By Business Segment
Series (USD Mn)	2016	2017	2018
Sales	16,861.7	19,562.3	20,634.4
R&D Expenditure	3,310.6	3,334.8	3,731.1

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Reports featuring Boehringer Ingelheim International

2 market reports profile this company.

Global Antihypertensive Drugs MarketPharmaceutical · Healthcare Global Veterinary Animal Vaccines MarketPharmaceutical · Healthcare

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →

About the Author

Wantstats Research Team

Wantstats' research desk profiles Boehringer Ingelheim International as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.